<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="18511">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02153710</url>
  </required_header>
  <id_info>
    <org_study_id>O1183-R</org_study_id>
    <nct_id>NCT02153710</nct_id>
  </id_info>
  <brief_title>Speech Therapy for Aphasia: Comparing Two Treatments</brief_title>
  <acronym>PMvSFA</acronym>
  <official_title>A Prospective, Controlled Study of Rehabilitation of Anomia in Aphasia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Department of Veterans Affairs</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Portland State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Department of Veterans Affairs</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a behavioral speech therapy trial for individuals who have suffered a stroke on the
      left side of the brain and have difficulty speaking. The name of this disorder is called
      &quot;aphasia.&quot; Individuals in this study will receive one of two treatments. The first is a
      phonological (sound level) treatment and the second is a semantic (word level) treatment.
      Individuals in both groups will receive 60 hours of therapy for free (2 hours/day, 5
      days/week, 6 weeks).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">October 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>spoken word production (confrontation naming)</measure>
    <time_frame>3 months following treatment termination (maintenance)</time_frame>
    <safety_issue>No</safety_issue>
    <description>Participants from both groups will be asked to name pictures not exposed during treatment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>response latency</measure>
    <time_frame>immediately and 3 months following treatment termination</time_frame>
    <safety_issue>No</safety_issue>
    <description>Participants from both groups will be measured on response latency during picture naming task. Response latency will be calculated for both trained and untrained items.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>verb production (confrontation naming)</measure>
    <time_frame>3 months following treatment termination</time_frame>
    <safety_issue>No</safety_issue>
    <description>Participants from both groups will be measured on verb naming accuracy. Verbs will be a linguistic context not exposed in treatment.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>Phonomotor therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Experimental group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Semantic Feature Analysis therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Current standard of care therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Speech therapy for aphasia: comparing two treatments</intervention_name>
    <description>We will compare two treatments for aphasia. Each participant will receive only one form of treatment.</description>
    <arm_group_label>Phonomotor therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Semantic Feature Analysis therapy</intervention_name>
    <description>Control therapy; current standard of care therapy</description>
    <arm_group_label>Semantic Feature Analysis therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Single, left-hemisphere stroke

          -  English as primary language prior to stroke

        Exclusion Criteria:

          -  Other neurological disorders

          -  Untreated depression
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diane L. Kendall, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Puget Sound Health Care System, Seattle</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diane L Kendall, PhD</last_name>
    <phone>(206) 764-2028</phone>
    <email>diane.kendall@va.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Megan S Oelke</last_name>
    <phone>(206) 277-4324</phone>
    <email>Megan.Oelke@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>VA Puget Sound Health Care System, Seattle</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robin Boland</last_name>
      <phone>206-277-1417</phone>
      <email>Robin.Boland@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Charles G Keelin</last_name>
      <phone>(206) 764-2028</phone>
      <email>charles.keelin2@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Diane L. Kendall, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 30, 2014</lastchanged_date>
  <firstreceived_date>March 20, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Aphasia</keyword>
  <keyword>Anomia</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Aphasia</mesh_term>
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
